ECMO在肺移植中快速改变初级止血:PFA-200观察性研究
该观察性研究在32例肺移植术中接受静脉-动脉ECMO支持的患者中,于ECMO支持前、中、后检测PFA-200、ROTEM血小板及血管性血友病因子(vWF)相关指标,发现ECMO支持期间三项PFA-200检测均显著恶化、停止后快速恢复,vWF抗原在ECMO停止后显著升高。
要点
- 短期ECMO支持会诱发初级止血病理,PFA-200三项检测在支持期间显著恶化。
- ECMO停止后PFA-200结果快速恢复,但ROTEM血小板仍显示持续血小板功能障碍。
- ECMO停止后vWF抗原显著升高,可能解释PFA-200所测初级止血功能正常。
核心结论
- 短期ECMO支持会诱发初级止血病理,该病理在ECMO启动后立即出现,但在ECMO停止后快速恢复,可由PFA-200检测发现。
- 尽管ECMO停止后ROTEM血小板结果仍显示持续血小板功能障碍,但vWF抗原水平升高可能解释PFA-200检测的初级止血结果正常。
研究设计与样本
- 观察性研究,纳入接受术中静脉-动脉ECMO支持的肺移植手术患者,共分析32例患者的血样本。
- 在ECMO支持前、支持期间及支持后采集血样本,检测PFA-200、ROTEM血小板、vWF抗原、瑞斯托霉素辅因子(RCo)及胶原结合蛋白(CB)。
主要发现
- 所有3项PFA-200检测(COL/EPI、COL/ADP及COL/P2Y)在ECMO支持期间显著恶化,ECMO停止后快速恢复(p < 0.05)。
- ECMO停止后vWF抗原显著升高(p < 0.05),RCo和CB水平升高但不显著(p > 0.05)。
- ECMO停止后ROTEM血小板结果仍显示持续血小板功能障碍。
关键数值与推荐
- PFA-200三项检测在ECMO支持期间显著恶化且停止后快速恢复,p < 0.05。
- ECMO停止后vWF抗原显著升高,p < 0.05。
- ECMO停止后RCo和CB水平升高但不显著,p > 0.05。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathology of primary hemostasis is a common complication of extracorporeal membrane oxygenation (ECMO) support. Scientific data describing its changes in patients on short-term ECMO support and the ability and speed of the restoration of its functions are limited. AIMS: The aim of this study was to describe the pathology of primary hemostasis induced by short-term ECMO support and its development over time using PFA-200, ROTEM platelet, and von Willebrand factor (vWF) analyses. METHODS: In patients undergoing lung transplantation surgery using intraoperative veno-arterial ECMO support, blood samples were analyzed using the following tests: PFA-200, ROTEM platelet tests, vWF antigen, ristocetin cofactor (RCo), and collagen-binding protein (CB) before, during, and after ECMO support. RESULTS: Blood samples from 32 patients were analyzed. All 3 PFA-200 tests (COL/EPI, COL/ADP, and COL/P2Y) showed significant deterioration during ECMO support with rapid restoration after ECMO cessation (p < 0.05), suggesting an ECMO-induced primary hemostasis disorder. A significant increase of vWF antigen after ECMO cessation (p < 0.05) was found with an increase of RCo and CB levels, although it was not significant (p > 0.05). CONCLUSIONS: Short-term ECMO support induces primary hemostasis pathology. It occurs immediately after initiation but is rapidly restored after ECMO cessation, which is detectable by PFA-200. Despite there being persistent platelet dysfunction after ECMO cessation, as seen with the ROTEM platelet results, the increased levels of vWF antigen might explain the normal results of primary hemostasis detected by PFA-200.
引用
- Garaj M, Francesconi A, Durila M, et al. ECMO produces very rapid changes in primary hemostasis detected by PFA-200 during lung transplantation: An observational study. J Heart Lung Transplant. 2024. PMID: 39038564. doi:10.1016/j.healun.2024.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。